<p>* A total of 88 patients were included in the analysis (51 patients were not assessable for SN echogenicity by transcranial sonography). SN+ = substantia nigra hyperechogenicity positive; MIBG+ = cardiac MIBG scintigraphy positive; OE+ = olfactory testing positive.</p
SUMMARY The clinical value of combining exertional ECG and postexertional thallium (201T1) scin-tigr...
BACKGROUND AND PURPOSE: Increased echogenicity of the substantia nigra is a typical transcranial son...
Meta-iodbenzylguanidine scintigraphy (MIBG scintigraphy) shows reduced uptake in idiopathic Parkinso...
I-metaiodobenzylguanidine (MIBG) scintigraphy, olfactory testing, and substantia nigra (SN) hyperech...
We aimed to evaluate the utility of the combined use of cardiac 123I-metaiodobenzylguanidine (MIBG) ...
<p>Positive ratios of TCS, cardiac MIBG scintigraphy and olfactory function tests for the PD vs. PSP...
<p>Correlation between the TCS test, olfactory test, and cardiac MIBG scintigraphy results and clini...
<p>Positive ratio of TCS, cardiac MIBG scintigraphy and olfactory function tests in the PD and APS g...
Abstract Objectives Both hyposmia and substania nigra (SN) hyperechogenicity on trascranial sonograp...
Transcranial sonography (TCS) shows an increased echogenic area of the substantia nigra (SN) in pati...
Objective Numerous ultrasound studies have suggested that a typical enlarged area of echogenicity in...
Introduction: Hyposmia and substantia nigra hyperechogenicity (SN+) are characteristic markers of Pa...
ObjectiveIodine-123 metaiodobenzylguanidine (MIBG) cardiac scintigraphy has shown the potential to d...
Assessment of tissue viability has become an important issue in recent years. Scintigraphic measurem...
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used t...
SUMMARY The clinical value of combining exertional ECG and postexertional thallium (201T1) scin-tigr...
BACKGROUND AND PURPOSE: Increased echogenicity of the substantia nigra is a typical transcranial son...
Meta-iodbenzylguanidine scintigraphy (MIBG scintigraphy) shows reduced uptake in idiopathic Parkinso...
I-metaiodobenzylguanidine (MIBG) scintigraphy, olfactory testing, and substantia nigra (SN) hyperech...
We aimed to evaluate the utility of the combined use of cardiac 123I-metaiodobenzylguanidine (MIBG) ...
<p>Positive ratios of TCS, cardiac MIBG scintigraphy and olfactory function tests for the PD vs. PSP...
<p>Correlation between the TCS test, olfactory test, and cardiac MIBG scintigraphy results and clini...
<p>Positive ratio of TCS, cardiac MIBG scintigraphy and olfactory function tests in the PD and APS g...
Abstract Objectives Both hyposmia and substania nigra (SN) hyperechogenicity on trascranial sonograp...
Transcranial sonography (TCS) shows an increased echogenic area of the substantia nigra (SN) in pati...
Objective Numerous ultrasound studies have suggested that a typical enlarged area of echogenicity in...
Introduction: Hyposmia and substantia nigra hyperechogenicity (SN+) are characteristic markers of Pa...
ObjectiveIodine-123 metaiodobenzylguanidine (MIBG) cardiac scintigraphy has shown the potential to d...
Assessment of tissue viability has become an important issue in recent years. Scintigraphic measurem...
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used t...
SUMMARY The clinical value of combining exertional ECG and postexertional thallium (201T1) scin-tigr...
BACKGROUND AND PURPOSE: Increased echogenicity of the substantia nigra is a typical transcranial son...
Meta-iodbenzylguanidine scintigraphy (MIBG scintigraphy) shows reduced uptake in idiopathic Parkinso...